BIOTEST AG (BIO.DE) Stock Income Statement
FRA:BIO - Deutsche Boerse Ag - DE0005227201 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 726.20M | 684.60M | 516.10M | 515.60M | 484.20M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 502.40M | 404.30M | 391.20M | 434.90M | 354.10M | |||
| Gross Profit | 223.80M | 280.30M | 124.90M | 80.70M | 130.10M | |||
| Operating Expenses | 137.20M | 160.00M | 141.50M | 130.90M | 132.40M | |||
| Research and Development | 56.10M | 66.20M | 49.90M | 51.70M | 55.10M | |||
| Selling, General, and Administrative Expenses | 79.60M | 73.20M | 72.90M | 72.70M | 69.30M | |||
| Operating Income | 86.60M | 120.30M | -16.60M | -50.20M | -2.30M | |||
| Interest Income/Expense | -45.50M | -35.20M | -9.20M | -12.00M | -24.80M | |||
| Other Income/Expense | -2.50M | -2.00M | -5.00M | -3.50M | -3.90M | |||
| Non Recurring Items | 7.90M | 23.20M | 0.00 | 3.10M | 1.00M | |||
| Income Before Taxes | 46.50M | 106.30M | -30.80M | -62.60M | -30.00M | |||
| Income Tax | 20.20M | -20.70M | 800.00K | 700.00K | 1.40M | |||
| Net Income | 26.40M | 127.00M | -32.49M | -64.99M | -32.18M | |||
| EBITDA | 127.20M | 156.20M | 19.20M | -19.10M | 27.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.67 | 3.21 | -0.82 | -1.64 | -0.81 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -0.84 | |||
| Statistics | ||||||||
| Gross Profit Margin | 30.82% | 40.94% | 24.20% | 15.65% | 26.87% | |||
| Profit Margin | 3.64% | 18.55% | -6.30% | -12.60% | -6.65% | |||
| Operating Profit Margin | 11.93% | 17.57% | -3.22% | -9.74% | -0.48% | |||
All data in EUR